Citations

Mayo Clinic

Showing 10 of 108572 citations.

Risk Factors for Readmission in Patients With Cancer Comanaged by Hospitalists
Shapiro, Joshua S., Humeniuk, Michael, Siddiqui, Mustaqeem , Bonthu, Neelima, Schroeder, Darrell R. , Kashiwagi, Deanne T. , Siddiqui, Mustaqeem A, Siddiqui, Mustaqeem A , Schroeder, Darrell

American Journal of Medical Quality | August 26, 2016 | Volume: 32 | Issue: 5 | Pages: 526-531

10.1177/1062860616665904 | PMID 27561695 Get It

Little is known about which variables put patients with cancer at risk for 30-day hospital readmission. Comanagement of this often complex patient population by specialists and hospitalists has become increasingly common. This retrospective study examined inpatients with cancer comanaged by hospitalists, hematologists, and oncologists to determine the rate of readmission and factors associated with readmission. Patients in this cohort had a readmission rate of 23%. Patients who were discharged to a skilled nursing facility (odds ratio [OR] = 0.34) or hospice (OR = 0.11) were less likely to have 30-day readmissions, whereas patients who had surgery (OR = 3.16) during their index admission were more likely. Other factors, including patient demographics, cancer types, and hospitalization interventions and events, did not differ between patients who were readmitted and those who were not. These findings contribute to a growing body of literature identifying risk factors for readmission in medical oncology and hematology patients.
Enterococcus faecalis readily colonizes the entire gastrointestinal tract and forms biofilms in a germ-free mouse model
Barnes, Aaron M. T. , Dale, Jennifer L. , Chen, Yuqing , Manias, Dawn A., Quaintance, Kerryl E. Greenwood, Karau, Melissa K., Kashyap, Purna , Patel, Robin , Wells, Carol L., Dunny, Gary M. , Greenwood Quaintance, Kerryl E, Karau, Melissa , Patel, Robin

Virulence | August 25, 2016 | Volume: 8 | Issue: 3 | Pages: 282-296

10.1080/21505594.2016.1208890 | PMID 27562711 Get It

Single-Coil Defibrillator Leads Yield Satisfactory Defibrillation Safety Margin in Hypertrophic Cardiomyopathy
Okamura, Hideo , Friedman, Paul A. , Inoue, Yuko , Noda, Takashi , Aiba, Takeshi , Yasuda, Satoshi , Ogawa, Hisao , Kamakura, Shiro, Espinosa, Raúl E. , Aiba, Takeshi , KUSANO, KENGO FUKUSHIMA

Circulation Journal | August 25, 2016 | Volume: 80 | Issue: 10 | Pages: 2199-2203

10.1253/circj.cj-16-0428 | PMID 27568735 Get It

Hemodynamic Transesophageal Echocardiography-Guided Venous-Arterial Extracorporeal Membrane Oxygenation Support in a Case of Giant Cell Myocarditis
Ripoll, Juan G. , Ratzlaff, Robert A. , Menke, David M. , Olave, Maria C. , Maleszewski, Joseph J. , Díaz-Gómez, José L , Díaz‐Gómez, José L.

Case Reports in Critical Care | August 25, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-6

10.1155/2016/5407597 | PMID 27648312 Get It

Giant cell myocarditis (GCM) is a rare and commonly fatal form of fulminant myocarditis. During the acute phase, while immunosuppressive therapy is initiated, venoarterial extracorporeal membrane oxygenation (VA-ECMO) support is commonly used as a bridge to heart transplantation or recovery. Until recently, conventional transesophageal echocardiography and transthoracic echocardiography were the tools available for hemodynamic assessment of patients on this form of mechanical circulatory support. Nevertheless, both techniques have their limitations. We present a case of a 54-year-old man diagnosed with GCM requiring VA-ECMO support that was monitored under a novel miniaturized transesophageal echocardiography (hTEE) probe recently approved for 72 hours of continuous hemodynamic monitoring. Our case highlights the value of this novel, flexible, and disposable device for hemodynamic monitoring, accurate therapy guidance, and potential VA-ECMO weaning process of patients with this form of severe myocarditis.
Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone
Tan, H. Y. , Steyn, Frederik J. , Huang, Lili , Cowley, Michael A. , Veldhuis, Johannes D. , Chen, Chen , Steyn, F J , Chen, C

The Journal of Physiology | August 25, 2016 | Volume: 594 | Issue: 24 | Pages: 7309-7326

10.1113/jp272770 | PMID 27558671 Get It

Key points Loss of function of the melanocortin 4 receptor (MC4R) results in hyperphagia, obesity and increased growth. Despite knowing that MC4Rs control food intake, we are yet to understand why defects in the function of the MC4R receptor contribute to rapid linear growth. We show that hyperphagia following germline loss of MC4R in male mice promotes growth while suppressing the growth hormone–insulin‐like growth factor‐1 (GH–IGF‐1) axis. We propose that hyperinsulinaemia promotes growth while suppressing the GH–IGF‐1 axis. It is argued that physiological responses essential to maintain energy flux override conventional mechanisms of pubertal growth to promote the storage of excess energy while ensuring growth. AbstractDefects in melanocortin‐4‐receptor (MC4R) signalling result in hyperphagia, obesity and increased growth. Clinical observations suggest that loss of MC4R function may enhance growth hormone (GH)‐mediated growth, although this remains untested. Using male mice with germline loss of the MC4R, we assessed pulsatile GH release and insulin‐like growth factor‐1 (IGF‐1) production and/or release relative to pubertal growth. We demonstrate early‐onset suppression of GH release in rapidly growing MC4R deficient (MC4RKO) mice, confirming that increased linear growth in MC4RKO mice does not occur in response to enhanced activation of the GH–IGF‐1 axis. The progressive suppression of GH release in MC4RKO mice occurred alongside increased adiposity and the progressive worsening of hyperphagia‐associated hyperinsulinaemia. We next prevented hyperphagia in MC4RKO mice through restricting calorie intake in these mice to match that of wild‐type (WT) littermates. Pair feeding of MC4RKO mice did not prevent increased adiposity, but attenuated hyperinsulinaemia, recovered GH release, and normalized linear growth rate to that seen in pair‐fed WT littermate controls. We conclude that the suppression of GH release in MC4RKO mice occurs independently of increased adipose mass, and is a consequence of hyperphagia‐associated hyperinsulinaemia. It is proposed that physiological responses essential to maintain energy flux (hyperinsulinaemia and the suppression of GH release) override conventional mechanisms of pubertal growth to promote the storage of excess energy while ensuring growth. Implications of these findings are likely to extend beyond individuals with defects in MC4R signalling, encompassing physiological changes central to mechanisms of growth and energy homeostasis universal to hyperphagia‐associated childhood‐onset obesity.
AMPA receptors
Benarroch, Eduardo E.

Neurology | August 25, 2016 | Volume: 87 | Issue: 12 | Pages: 1281-1288

10.1212/wnl.0000000000003138 | PMID 27558370 Get It

Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT
Sasaguri, Kohei, Takahashi, Naoki , Takeuchi, Mitsuru , Carter, Rickey E. , Leibovich, Bradley C. , Kawashima, Akira , Carter, Rickey E , Takahashi, Naoki

American Journal of Roentgenology | August 24, 2016 | Volume: 207 | Issue: 5 | Pages: 1031-1038

10.2214/ajr.16.16193 | PMID 27556736 Get It

Integrative Medicine Preferences Among Coccidioidomycosis (Valley Fever) Patients
Short, Jack H., Bradley, Constance, Blair, Janis E. , Stewart, Terry D., Burns, Mark W. , Patron, Roberto L. , Millstine, Denise , Millstine, Denise M

The Journal of Alternative and Complementary Medicine: Paradigm, Practice, and Policy Advancing Integrative Health | August 24, 2016 | Volume: 23 | Issue: 2 | Pages: 135-139

10.1089/acm.2016.0139 | PMID 27557127 Get It

Objectives: To understand the extent and modalities of integrative medicine strategies that patients with coccidioidomycosis (valley fever) have incorporated into their treatment regimens. Design: A direct patient survey was distributed, with 100 unique responses, at a single infectious diseases clinic at an academic medical center in Arizona. Eligible patients, defined as those with confirmed coccidioidomycosis or currently under evaluation, were polled on their personal use of 36 integrative medicine modalities. Patients were also asked to indicate their level of fatigue on a 10-point scale in an attempt to correlate levels of fatigue to use of specific integrative medicine modalities. Results: Of the patients surveyed, 64% had used at least one integrative medicine modality, and 53% used two or more, along with conventional medical therapy. The top three modalities were nutrition (39%), massage (27%), and breathing exercises (26%). The mean reported fatigue level was 4.7 on a 10-point scale, with a standard deviation of 3.0. There was no statistically significant association between use of a specific modality and reported level of fatigue. Conclusions: Nearly two thirds of patients (64%) surveyed had used at least one integrative medicine modality throughout the course of their therapy. Clinicians are probably unaware of the extent to which many patients, including this population, have embraced integrative medicine. Awareness of patients' goal and preferences is valuable in shared clinical decision making.
Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
Galgiani, John N. , Ampel, Neil M. , Blair, Janis E. , Catanzaro, Antonino , Geertsma, Francesca, Hoover, Susan E. , Johnson, Royce H. , Kusne, Shimon , Lisse, Jeffrey , MacDonald, Joel D., Meyerson, Shari L. , Raksin, P B , Siever, John, Stevens, David A. , Sunenshine, Rebecca, Siever, John, Theodore, Nicholas

Clinical Infectious Diseases | August 24, 2016 | Volume: 63 | Issue: 6 | Pages: 717-722

10.1093/cid/ciw538 | PMID 27559032 Get It

Abstract It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. Infectious Diseases Society of America considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances. Coccidioidomycosis, also known as San Joaquin Valley fever, is a systemic infection endemic to parts of the southwestern United States and elsewhere in the Western Hemisphere. Residence in and recent travel to these areas are critical elements for the accurate recognition of patients who develop this infection. In this practice guideline, we have organized our recommendations to address actionable questions concerning the entire spectrum of clinical syndromes. These can range from initial pulmonary infection, which eventually resolves whether or not antifungal therapy is administered, to a variety of pulmonary and extrapulmonary complications. Additional recommendations address management of coccidioidomycosis occurring for special at-risk populations. Finally, preemptive management strategies are outlined in certain at-risk populations and after unintentional laboratory exposure.